Tag Archives: disease progression
Yunzhi Slows Progression of Advanced Non-small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is a leading cause of cancer deaths, but most patients (over 69%) were diagnosed at advanced stages. Although polysaccharide peptides (PSP), isolated from the fungus Yunzhi (Coriolus versicolor), have been reported to have anti-tumor effects … Continue reading
FDA Panel Supports the Use of Vandetanib in Medullary Thyroid Cancer
An FDA advisory committee reported that they supported the use of AstraZeneca’s vandetanib for the treatment of patients with medullary thyroid cancer (MTC). However, they also indicated the drug should be reserved for patients who are experiencing symptoms of their … Continue reading
Cetuximab (Erbitux) Reduces Disease Progression in Triple Negative Breast Cancer
Patients with triple negative breast cancer usually have poor prognosis, but a new drug might soon be available to improve the survival in these patients. Mid-stage study results presented at the European Society for Medical Oncology congress indicated that cetuximab(Erbitux) … Continue reading